logo
    Docs
 

Disease Report: Crohn's Disease


Groups and Companies
Funding
Standard of Care
Unmet Medical Need
Novel Modalities and Combinations
Symptoms Evidence
Symptoms Targets
Pathogenesis Evidence
Pathogenesis Targets
Assays and Models

1. Hypothesis summary:

The hypothesis posits that patients with Crohn's disease may experience symptoms such as weight loss, fatigue, and anemia due to nutritional deficiencies stemming from malabsorption. This is particularly significant when the disease affects the small intestine, which is primarily responsible for nutrient absorption.

2. Mechanism and evidence:

Crohn's disease (CD) is characterized by chronic inflammation of the gastrointestinal tract, which can lead to structural changes and damage to the intestinal lining. This damage impairs the absorption of essential nutrients, resulting in deficiencies. The mechanisms include:
  • Inflammation: Inflammatory cytokines can disrupt the intestinal barrier and alter gut permeability, leading to malabsorption (Forbes et al., 2017, PMID: 28131521).
  • Surgical Resection: Surgical interventions, often necessary in CD, can remove sections of the intestine, further reducing the surface area available for nutrient absorption (Hashash et al., 2024, PMID: 38276922).
  • Dietary Restrictions: Patients may avoid certain foods due to symptoms, leading to inadequate nutrient intake (Kamel et al., 2024, PMID: 39012640).

3. Clinical evidence:

  • Prevalence of Malnutrition: Studies indicate that malnutrition affects 65-75% of patients with Crohn's disease, with deficiencies in iron, zinc, magnesium, and vitamins B12, D, A, E, and K being common (Caio et al., 2021, PMID: 34066229).
  • Symptoms Correlation: Nutritional deficiencies are linked to symptoms such as anemia (iron and vitamin B12 deficiencies), fatigue (often associated with anemia), and significant weight loss (Jablonska et al., 2023, PMID: 37111210; Hindryckx et al., 2018, PMID: 28852978).

4. Genetic targets and evidence:

While specific genetic targets related to nutrient absorption in Crohn's disease are not extensively documented, genetic predispositions to inflammatory bowel diseases can influence nutrient metabolism and absorption. For example, polymorphisms in genes related to inflammation may affect the severity of malabsorption (Forbes et al., 2017, PMID: 28131521).

5. Protein targets and evidence:

Proteins involved in nutrient transport and metabolism, such as the vitamin B12 transporter (TCN2) and iron transport proteins (ferroportin), may be affected in patients with Crohn's disease. Deficiencies in these proteins can exacerbate malabsorption and contribute to anemia and fatigue (Kamel et al., 2024, PMID: 39012640).

6. Pathways and evidence:

The inflammatory pathways activated in Crohn's disease, including the NF-kB and JAK-STAT pathways, can lead to increased intestinal permeability and altered nutrient absorption. These pathways are crucial in mediating the inflammatory response and can directly impact nutrient absorption (Forbes et al., 2017, PMID: 28131521).

7. Cellular targets and evidence:

Enterocytes, the absorptive cells of the intestine, are directly affected by inflammation in Crohn's disease. Damage to these cells impairs their ability to absorb nutrients effectively, leading to deficiencies (Hashash et al., 2024, PMID: 38276922).

8. Tissue targets and evidence:

The small intestine is the primary site of nutrient absorption, and inflammation or damage in this area due to Crohn's disease significantly impacts nutritional status. Studies show that patients with ileal involvement are at higher risk for deficiencies (Caio et al., 2021, PMID: 34066229).

9. Additional context:

Nutritional management is critical in Crohn's disease, with guidelines recommending regular screening for malnutrition and tailored dietary interventions. Enteral nutrition has been shown to be effective in inducing remission and correcting malnutrition, particularly in children (Hashash et al., 2024, PMID: 38276922). However, the role of diet remains controversial, and there is no one-size-fits-all approach, emphasizing the need for individualized care (Forbes et al., 2017, PMID: 28131521).
In conclusion, the evidence supports the hypothesis that nutritional deficiencies due to malabsorption in Crohn's disease can lead to significant symptoms such as weight loss, fatigue, and anemia, particularly when the small intestine is affected. Regular nutritional assessment and intervention are essential components of managing Crohn's disease to mitigate these complications.